3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
35
Neoplasms
23
Motor Activity
11
Stomach Neoplasms
7
Pain, Postoperative
7
Lung Neoplasms
7
Fatigue
7
Colorectal Neoplasms
7
Pain
5
Anxiety Disorders
5
Polycystic Ovary Syndrome
4
Depression
4
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Thyroid Neoplasms
3
Stomatitis
3
Sleep Initiation and Maintenance Disorders
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Malnutrition
3
Liver Neoplasms
3
Leukemia, Myeloid, Acute
3
Colonic Neoplasms
3
Agnosia
3
Vomiting
2
Urinary Incontinence
2
Squamous Cell Carcinoma of Head and Neck
2
Parasomnias
2
Ovarian Neoplasms
2
Interventions
Cisplatin
21
pembrolizumab
16
Gemcitabine
16
Paclitaxel
15
Radiotherapy
14
Carboplatin
14
Radiotherapy, Intensity-Modulated
13
Cyclophosphamide
9
Cetuximab
9
Magnetic Resonance Spectroscopy
8
Radiation
7
padeliporfin
6
Specimen Handling
6
Oxaliplatin
6
Fluorouracil
6
Drug Therapy
6
Docetaxel
6
Capecitabine
6
Bevacizumab
6
anlotinib
5
Nivolumab
5
Irinotecan
5
Erlotinib Hydrochloride
5
Celecoxib
5
poly ICLC
4
fludarabine
4
Standard of Care
4
Sorafenib
4
Leucovorin
4
Ipilimumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma
×
Control Groups
×
Clear all
NCT04104334
2021-10-08
CHIPNOL
Ciusss de L'Est de l'Île de Montréal
Phase NA
Terminated
9 enrolled